Editorial review
Educational content is reviewed for source quality, clinical boundaries, and readability. It is not medical advice; confirm care decisions with a licensed clinician.
A ketamine troche is a compounded lozenge you hold against your cheek or under your tongue for about 10 to 15 minutes so the medication absorbs through the mucosal tissue before the remainder is swallowed. A rapid-dissolve tablet (RDT) is formulated to break apart in seconds to a couple of minutes, which shortens hold time but also sends more of the dose past the mouth to be swallowed and processed by the liver rather than absorbed sublingually. Neither product is FDA-approved. Both are dispensed off-label by a compounding pharmacy under a prescriber's order, and only esketamine (Spravato) nasal spray holds FDA approval for treatment-resistant depression, administered only in a certified clinical setting.
Quick Answer
Ketamine troches dissolve slowly over 10 to 15 minutes while held in the cheek or under the tongue, giving the drug more contact time with the oral mucosa before any of it is swallowed. Rapid-dissolve tablets break down in under a couple of minutes, which is more convenient but can route a larger share of the dose through the stomach and liver instead of sublingual tissue. Both are compounded, off-label ketamine products from a licensed compounding pharmacy, not FDA-approved medications. The better fit depends on how long you can realistically hold a dose in place, your prescriber's absorption goals, and how your specific pharmacy formulates each product.
What a Ketamine Troche Is
A troche is a solid, flavored lozenge made by dissolving powdered ketamine into a base, most often a wax or polymer that erodes slowly in saliva. You place it between your cheek and gum or under your tongue and let it dissolve fully, resisting the urge to chew or swallow it early. Compounding pharmacies that follow United States Pharmacopeia (USP) Chapter 795 standards for non-sterile compounding test each batch for potency and uniformity, which matters because troches are custom-made rather than mass-manufactured. Read more about how those standards apply to USP 795 compounding standards for ketamine troches.
What a Rapid-Dissolve Tablet Is
A rapid-dissolve tablet, sometimes labeled an orally disintegrating tablet (ODT), uses a porous or freeze-dried base designed to break apart on contact with saliva. Instead of a 10 to 15 minute hold, an RDT can be gone from the mouth in a minute or two. That speed is the appeal, but it is also the tradeoff: less time in contact with the sublingual or buccal tissue means a larger fraction of the dose is likely to be swallowed and pass through the gut and liver before reaching circulation, a process pharmacologists call first-pass metabolism. Your prescriber's onset and duration expectations are typically set around the troche's slower release, so switching forms is a change worth discussing rather than assuming interchangeable. See the typical ketamine troche onset, peak, and duration timeline for what a standard troche session looks like.
Compare troche options
Compare troches with other ketamine routes and safety considerations.
Compare optionsTroche vs Rapid-Dissolve Tablet
| Feature | Ketamine Troche | RecommendedRapid-Dissolve Tablet |
|---|---|---|
| Typical dissolve time | 10 to 15 minutes | Under 1 to 2 minutes |
| Administration | Held in cheek or under tongue until fully gone | Placed under tongue, dissolves quickly on its own |
| Mucosal contact time | Longer, more consistent | Shorter, more variable |
| Regulatory status | Compounded, off-label | Compounded, off-label |
| Dose customization | Flexible custom strengths per prescription | Flexible custom strengths per prescription |
| Best suited for | Patients who can hold a dose in place for the full session | Patients who struggle with a long hold time |
Why Hold Time Changes Absorption
Sublingual and buccal tissue is thin and rich with blood vessels, which lets a drug cross into circulation without first passing through the liver. The longer a dose stays in contact with that tissue, the more of it takes that route instead of being swallowed. A troche's slow-eroding base is built to stretch that contact window to the 10 to 15 minute range prescribers typically plan around. An RDT's fast breakdown compresses that window, so more of the dose may end up swallowed and metabolized in the gut and liver, which can change how much active drug reaches circulation and how the effect feels compared with a troche at the same labeled strength.
This is one reason a troche and an RDT at the same milligram count are not automatically equivalent doses in practice. If you are also comparing routes beyond sublingual forms, see how troches stack up against oral capsules for PTSD treatment outcomes and against Spravato nasal spray for effectiveness, the one ketamine-derived product with FDA approval.
Troche Advantages Over an RDT
- Longer mucosal contact time gives a more predictable, prescriber-planned absorption window
- Slow dissolve makes it easier to notice and pause a session if something feels off
- Established dosing history at most compounding pharmacies, since troches are the more common ketamine format
Troche Tradeoffs Versus an RDT
- Requires 10 to 15 minutes of sitting still without talking, eating, or drinking
- Flavor and texture can be harder to tolerate for a full hold than a fast-dissolving tablet
- Less convenient for someone who needs to administer a dose in a shorter window
Supervision Applies to Both Forms
Switching between a troche and a rapid-dissolve tablet without your prescriber's sign-off can change how much drug you absorb at the same labeled dose, because the two forms differ in mucosal contact time. Any at-home ketamine session, regardless of format, should follow your prescriber's protocol for a quiet, seated setting and a sitter or check-in plan. Review whether you need a sitter for a ketamine troche session and the full ketamine troche safety guide before changing formats.
Cost and Access Differences
Both troches and RDTs are compounded to order, so price is driven mainly by the compounding pharmacy's process and the prescribed strength, not by which format you choose. Neither is likely to carry standard insurance coverage, since both are off-label compounded products rather than FDA-approved drugs. Some insurance plans provide partial reimbursement for the prescriber visit or monitoring, even when the compounded medication itself is a self-pay item; details on what insurance typically does and does not cover can help you budget before you commit to either format. If cost comparisons matter to your decision, it is also worth weighing sublingual forms against infusion therapy for chronic pain management, which runs on a clinic-visit pricing model rather than a per-dose pharmacy cost.
Questions to Bring to Your Prescriber
- Ask whether your compounding pharmacy offers both troche and RDT formats at the same strength
- Ask how switching formats would change your labeled dose or your monitoring schedule
- Confirm how long you need to hold the dose for each format before swallowing
- Ask what onset and duration to expect for the specific format you are prescribed
- Confirm your sitter or check-in plan applies the same way to both formats
Key Takeaway
The choice between a ketamine troche and a rapid-dissolve tablet is really a choice about how long you can hold a dose in place and how your prescriber wants to manage absorption, not a matter of one format being universally better.
Find a Prescriber Who Can Guide the Format Decision
A ketamine-informed prescriber and compounding pharmacy can tell you which sublingual form fits your routine and monitor you through the switch. Get help finding one.
Frequently Asked Questions
No. Both are compounded, off-label sublingual ketamine products, but a troche is a slow-eroding lozenge meant to be held for 10 to 15 minutes, while a rapid-dissolve tablet is built to break apart in a minute or two.
Longer contact with the oral mucosa generally means more of the dose is absorbed sublingually rather than swallowed, which favors the troche's slower dissolve. An RDT's faster breakdown may route more of the dose through the gut and liver instead, though individual technique and pharmacy formulation both affect the result.
You should not. Because the two formats differ in mucosal contact time, the same labeled milligram amount may not produce the same absorbed dose. Any format change should go through your prescriber and compounding pharmacy.
Not inherently. Compounding cost is driven mainly by the pharmacy's process and the prescribed strength rather than the specific dosage form, and neither format typically carries standard insurance coverage since both are compounded off-label.
No. Compounded ketamine troches and rapid-dissolve tablets are prescribed off-label. Only esketamine (Spravato) nasal spray carries FDA approval for treatment-resistant depression, and it is administered only in a certified clinical setting.
Share
Related Reading
Contact Ketamine Troche
Send corrections, provider questions, or advertising inquiries.